What’s on FDA’s new Diagnostics Chief’s mind? Transitions, the LDT rule and cybersecurity

By Laura DiAngelo, MPH

COURTNEY LIAS has been Acting Director of CDRH’s in vitro diagnostics office, known as OHT7, since the departure of TIM STENZEL at the end of 2023. At a conference in DC this week, she confirmed that she is now the permanent Director of OHT7. She takes over the office at a critical time for the office, which is at the forefront of several major regulatory reform efforts.

The Center for Devices and Radiological Health (CDRH) is organized into seven main Offices, of which one – the Office of Product Evaluation and Quality (OPEQ) – is a “super office.”

Fill out the form to read the full article.